# Rainbow Childrens Medicare (NSE: RAINBOW) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/RAINBOW · Pivot · prices to 22 Oct 2026

Rainbow Childrens Medicare (NSE: RAINBOW) closed at ₹1,205.70 on 22 Oct 2026, down 0.27% on the day. With a market capitalisation of ₹12,184 Cr, it ranks 503rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.

At its last close the stock traded at 43.9× trailing earnings, against a return on equity of 16.9% in FY26. Over the past year the share price has fallen 9.4%. Its 52-week range is ₹1,084.00 (23 Mar 2026) to ₹1,610.00 (5 Aug 2026); the last close is 25.1% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹470 Cr (+33.2% year on year) and net profit ₹63 Cr (+16.2%), on a consolidated basis. Promoters held 49.84% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,205.70 |
| Market cap | ₹12,184 Cr |
| P/E (trailing) | 43.9 |
| ROE | 16.9% (FY26) |
| ROCE | 16.9% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹1,610.00 (5 Aug 2026) |
| 52-week low | ₹1,084.00 (23 Mar 2026) |
| 1-year return | −9.4% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹470 Cr | +33.2% | ₹63 Cr | +16.2% | ₹5.97 |
| Q4 FY26 | ₹460 Cr | +24.3% | ₹78 Cr | +38.3% | ₹7.59 |
| Q3 FY26 | ₹445 Cr | +11.9% | ₹74 Cr | +7.2% | ₹7.14 |
| Q2 FY26 | ₹445 Cr | +6.5% | ₹76 Cr | −4.3% | ₹7.41 |
| Q1 FY26 | ₹353 Cr | +6.9% | ₹54 Cr | +35.4% | ₹5.27 |
| Q4 FY25 | ₹370 Cr | +8.5% | ₹57 Cr | +10.7% | ₹5.55 |
| Q3 FY25 | ₹398 Cr | +18.5% | ₹69 Cr | +10.2% | ₹6.76 |
| Q2 FY25 | ₹417 Cr | +25.5% | ₹79 Cr | +25.1% | ₹7.77 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹1,516 Cr | ₹244 Cr |
| FY24 | ₹1,297 Cr | ₹218 Cr |
| FY23 | ₹1,174 Cr | ₹212 Cr |
| FY22 | ₹974 Cr | ₹139 Cr |
| FY21 | ₹650 Cr | ₹40 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 49.84%
- Foreign institutions: 16.03%
- Domestic institutions: 22.56%
- Non-institutions: 11.39%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Marksans Pharma](https://app.pivotnow.in/stock/MARKSANS) | ₹295.80 | ₹13,343 Cr | 32.1 | 13.8% |
| [Concord Biotech](https://app.pivotnow.in/stock/CONCORDBIO) | ₹1,298.00 | ₹13,294 Cr | 52.4 | — |
| [CORONA Remedies](https://app.pivotnow.in/stock/CORONA) | ₹2,024.70 | ₹12,500 Cr | 66.8 | 24.8% |
| [Sudeep Pharma](https://app.pivotnow.in/stock/SUDEEPPHRM) | ₹984.90 | ₹11,124 Cr | 66.2 | — |
| [Metropolis Healthcare](https://app.pivotnow.in/stock/METROPOLIS) | ₹532.25 | ₹11,035 Cr | 57.9 | — |
| [Akums Drugs and Pharmaceuticals](https://app.pivotnow.in/stock/AKUMS) | ₹690.85 | ₹10,874 Cr | 41.5 | — |

## Questions and answers

### What is the share price of Rainbow Childrens Medicare today?

Rainbow Childrens Medicare (NSE: RAINBOW) last closed at ₹1,205.70 on 22 Oct 2026. Its 52-week high is ₹1,610.00 and its 52-week low is ₹1,084.00.

### What is the market cap of Rainbow Childrens Medicare?

Rainbow Childrens Medicare's market capitalisation is ₹12,184 Cr (₹12,184 Cr) at the 22 Oct 2026 close, ranking 503rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Rainbow Childrens Medicare?

Rainbow Childrens Medicare trades at a trailing P/E of 43.9. The median P/E of the 6 closest Pharma & Healthcare peers by market cap is 57.9.

### What is the ROE and ROCE of Rainbow Childrens Medicare?

Return on equity was 16.9% in FY26 and return on capital employed was 16.9% in FY26 (consolidated figures).

### Is Rainbow Childrens Medicare a debt-free company?

Rainbow Childrens Medicare is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Rainbow Childrens Medicare's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Rainbow Childrens Medicare reported revenue of ₹470 Cr, +33.2% year on year, and net profit of ₹63 Cr, +16.2% year on year.

### How has Rainbow Childrens Medicare stock performed over the last year?

Rainbow Childrens Medicare's share price has fallen 9.4% over the past year, −18.7% over three months and −16.4% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Rainbow Childrens Medicare?

As of 30 Jun 2026: promoters 49.84%, foreign institutions 16.03%, domestic institutions 22.56%, non-institutions 11.39%.

### Who are Rainbow Childrens Medicare's competitors?

The listed Pharma & Healthcare companies closest to Rainbow Childrens Medicare by market cap are Marksans Pharma, Concord Biotech, CORONA Remedies, Sudeep Pharma, Metropolis Healthcare and Akums Drugs and Pharmaceuticals.

### Is Rainbow Childrens Medicare a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Rainbow Childrens Medicare's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on RAINBOW against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.